Pseudomyxoma Peritonei Syndrome of Appendiceal Origin: An Overview

Brueggen, Carol; Baird, Gayle; Meisheid, Allison

doi:10.1188/07.cjon.525-532

Cited by 10 publications

(20 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three types of PMP, namely PMP ascites type, nodular type and mixed type (5–11) have been reported in the literature. It appears that these three types are part of a continuous process; the nodular type occurs late in the process and evolves from PMP ascites.…”

Section: Discussionmentioning

confidence: 99%

Different medical expenses incurred by appendiceal cystadenoma in China: Report of three cases

Wang

Liu

et al. 2013

Oncology Letters

View full text Add to dashboard Cite

Appendiceal cystadenoma, the most common type of what has been generally termed ‘mucocele’ of the appendix, has unique clinical characteristics. In this study, three similar clinical manifestations of appendiceal cystadenoma are presented, with different subsequent management and diverse prognostic outcomes relating to the characteristics of the disease, the wishes of the patients, the medical workers and social factors. In this study, we provide details of three cases of appendiceal cystadenomas.

show abstract

Section: Discussionmentioning

confidence: 99%

Different medical expenses incurred by appendiceal cystadenoma in China: Report of three cases

Wang

Liu

et al. 2013

Oncology Letters

View full text Add to dashboard Cite

show abstract

“…10 Mucinous tumors of appendiceal origin are relatively rare; approximately 300 new cases are diagnosed each year in the United States. 11 Although these tumors are not considered as biologically aggressive, like PC associated with gastrointestinal adenocarcinomas, appendiceal tumors can nevertheless be fatal. Peritoneal carcinomatosis originating from the appendix is called PMP.…”

Section: ■ Peritoneal Surface Malignanciesmentioning

confidence: 99%

“…Symptoms may be insidious, such as an increase in abdominal girth, early satiety, enlarging hernia (in males), and ovarian mass (in females), or acute such as pelvic pain, nausea, vomiting, and changes in bowel or bladder habits. 11,12 Ovarian cancer arises from the epithelial surface of the ovary; it is the most common cause of cancer-related death from gynecologic tumors in the United States. 3 About 75% are initially diagnosed when they have progressed to stage II to IV tumors.…”

Section: ■ Peritoneal Surface Malignanciesmentioning

confidence: 99%

Surgical Treatment of Patients With Peritoneal Surface Malignancy

Dunn

2010

Journal of Wound, Ostomy &Amp; Continence Nursing

View full text Add to dashboard Cite

A peritoneal surface malignancy is one of an assortment of tumors that result in widespread peritoneal involvement, can affect multiple organs, and may arise from the appendix, colon, rectum, stomach, ovaries, or peritoneal lining. The combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy has gained recognition as a promising, potentially life-extending surgical treatment option for the management of peritoneal surface malignancies. This type of surgical treatment is not without risks and complications, often resulting in the formation of fistulas and the need for a diverting ostomy. This article presents a review of peritoneal surface malignancies, cytoreductive surgery, the perioperative management of the surgical patient with focus on complications and implications for the WOC nurse providing care for patients undergoing this complex surgical treatment.

show abstract

“…Pseudomyxoma peritonei (PMP) is a rare disease with the incidence of 1-2 cases per million per year [ 1,2]. It is slowly progressive condition that usually arises from perforation of appendix due to an enlarging appendiceal adenoma or carcinoma, allowing mucin producing neoplastic cells to gain access to peritoneal cavity.…”

Section: Introductionmentioning

confidence: 99%

Early Data Of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated By A Strategy Of Cytoreductive Surgery And Hyperthermic Intraperitoneal Chemotherapy

et al. 2016

View full text Add to dashboard Cite

Background. Appendiceal peritoneal pseudomyxoma (PMP) is very rare disease and its longterm prognosis is poor. The aim of this study was to evaluate the results of an aggressive treatment approach used in our institution for the last 4 years. Methods. We selected all patients with PMP from appendiceal origin who were treated by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) at the Klaipeda University Hospital between January 2012 and January 2016. Data from all patients with PMP arising from the appendix were retrospectively collected and analyzed. Treatment consisted of complete surgical cytoreduction , followed by hyperthermic intraperitoneal chemotherapy with mitomycin at 42°C over 90 minutes. Ronnett’s hystologic classification was used for tumor grading. Results. A total of 6 patients underwent cytoreduction and peritonectomy plus HIPEC. Median age at diagnosis was 57 years (range, 39-67). All our patients were female. The previous surgery score at the moment of admission was PSS-2 for three patients, PSS-3 for 3 patients. Four patients were diagnosed as diffuse peritoneal adenomucinosis (DRAM) and two as peritoneal mucinous carcinomatosis( PMCA). In all of the patients, optimal cytoreduction CC-0 (5 patients) and CC-1 (one patient) was achieved. The median peritoneal cancer index (PCI) was 17 (range, 14-25) as an indicator of disease extension.The median number of visceral resections performed per patient was 3 (range, 1-5). The median duration of CRS/HIPEC was 8 hours and 10 minutes (range, 7 hours and10 min. to 9 hours 20 min). Mean postoperative stay was 13 days (range, 8-18). The 30 days postoperative and in-hospital mortality were zero . One patient experienced temporary haemorhagic cystitis. The mean follow-up period was 28 months ( range, 8-45). At the time of analysis all patients are alive and without recurrence. Conclusions PMP from appendiceal origin can be treated with curative intent in a large percentage of cases by cytoreductive surgery associated with HIPEC. This new approach could be performed safely with acceptable morbidity and mortality in selected patients treated in specialized centers.

show abstract

Pseudomyxoma Peritonei Syndrome of Appendiceal Origin: An Overview

Cited by 10 publications

References 39 publications

Different medical expenses incurred by appendiceal cystadenoma in China: Report of three cases

Different medical expenses incurred by appendiceal cystadenoma in China: Report of three cases

Surgical Treatment of Patients With Peritoneal Surface Malignancy

Early Data Of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated By A Strategy Of Cytoreductive Surgery And Hyperthermic Intraperitoneal Chemotherapy

Contact Info

Product

Resources

About